The Administrative Core (Core A) is responsible for oversight of the entire CFAR. This is accomplished through organization of the monthly Core Directors' Meeting, through fiscal management of all CFAR funds, through management of the yearly core evaluation (alternating internal and external), and through interactions with the External Advisory Board. The CFAR Director, who is Director of Core A, and the Associate Director represent the CFAR to the administrations of the collaborating institutions, to the Internal Advisory Board, and to NIH. The Administrative Core is responsible for communicating with the CFAR membership about CFAR activities using email and web-based information and by creating networks of subsets of members. With the creation of the Office of Communications, Outreach, Dissemination, and Education within the Administrative Core these functions will now formally reside in this Core as part of the CFAR administrative structure. Through this Office the Administrative Core will engage its Community Advisory Board and extend its education and outreach efforts. In overseeing the activities of the entire CFAR the Administrative Core supports the mission of providing value added to NIH-sponsored HIV/AIDS-related research.

Public Health Relevance

The goals of the CFAR are to support all HIV/AIDS-related research. The HIV-1 epidemic represents a major health crisis worldwide and a major challenge to the biomedical community to develop effective behavioral interventions, barrier protection, vaccines, and sustainable therapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI050410-13
Application #
8080836
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2010-06-01
Budget End
2011-05-31
Support Year
13
Fiscal Year
2010
Total Cost
$586,954
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Henderson, Gail E; Peay, Holly L; Kroon, Eugene et al. (2018) Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment. J Med Ethics 44:270-276
Costenbader, Elizabeth; Mangone, Emily; Mueller, Monique et al. (2018) Rapid organizational network analysis to assess coordination of services for HIV testing clients: an exploratory study. J HIV AIDS Soc Serv 17:16-31
Honeycutt, Jenna B; Liao, Baolin; Nixon, Christopher C et al. (2018) T cells establish and maintain CNS viral infection in HIV-infected humanized mice. J Clin Invest 128:2862-2876
Zule, William A; Latypov, Alisher; Otiashvili, David et al. (2018) Feasibility of needle and syringe programs in Tajikistan distributing low dead space needles. Harm Reduct J 15:44
Howe, Chanelle J; Dulin-Keita, Akilah; Cole, Stephen R et al. (2018) Evaluating the Population Impact on Racial/Ethnic Disparities in HIV in Adulthood of Intervening on Specific Targets: A Conceptual and Methodological Framework. Am J Epidemiol 187:316-325
Ong, Jason J; Fu, Hongyun; Smith, M Kumi et al. (2018) Expanding syphilis testing: a scoping review of syphilis testing interventions among key populations. Expert Rev Anti Infect Ther 16:423-432
Gopal, Satish; Gross, Thomas G (2018) How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa. Blood 132:254-263
Rosenberg, Nora E; Graybill, Lauren A; Wesevich, Austin et al. (2018) Individual, Partner, and Couple Predictors of HIV Infection among Pregnant Women in Malawi: A Case-Control Study. AIDS Behav 22:1775-1786
Molloy, Síle F; Kanyama, Cecilia; Heyderman, Robert S et al. (2018) Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa. N Engl J Med 378:1004-1017
Montgomery, Nathan D; Tomoka, Tamiwe; Krysiak, Robert et al. (2018) Practical Successes in Telepathology Experiences in Africa. Clin Lab Med 38:141-150

Showing the most recent 10 out of 1688 publications